NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Flipper,

I know people are reticent to discuss deaths, or events as the FDA chooses to call them, but this is a very deadly cancer. I believe that most who failed to cross over had either passed on, or been too sick to take the treatment, by the time the treatment was properly offered to them. It's not about not choosing to take it, it's about life ending events occurring before such an option was available.

Perhaps in the Journal they'll go into depth on the patients who didn't cross over, then we'll know. I frankly don't believe that any entering the trial had forms of brain cancers that weren't deadly to well over 90% of them, not crossing over is very probably because you couldn't, not because you didn't choose to.

Gary